Veterinary Medicines

CANIVERM forte tablety

Authorised
  • Fenbendazole
  • Pyrantel embonate
  • Praziquantel
Download as PDF

Product identification

Medicine name:
CANIVERM forte tablety
Active substance:
  • Fenbendazole
  • Pyrantel embonate
  • Praziquantel
Target species:
  • Dog
  • Cat
  • Other Canids
  • Other Felids
Route of administration:
  • Oral use
  • In-feed use

Product details

Active substance and strength:
  • Fenbendazole
    150.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
    • Other Canids
    • Other Felids
  • In-feed use
    • Dog
    • Cat
    • Other Canids
    • Other Felids
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC30
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/013/13-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 19/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."